A Valuable COVID Drug Doesn’t Work against New Variants

    0
    128

    Current monoclonal antibodies fail against COVID virus variants, so drugmakers want to use a fast-track test for new ones

    Advertisment
    Previous articleTheraputicsMD sells products rights for $153 million
    Next articleCan Fla.’s Empty Shopping Plazas Become Housing?

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here